Caplin Point Lab

{
  "main_header": {
    "sid": 640544,
    "name": "Caplin Point Lab",
    "stock_name": "Caplin Point Lab",
    "full_name": "Caplin Point Laboratories Ltd",
    "name_url": "stocks-analysis/caplin-point-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,411.30",
    "chg": 80.5,
    "chgp": "3.45%",
    "dir": 1,
    "prev_price": "2,330.80",
    "mcapval": "17,996.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524742,
    "symbol": "CAPLIPOINT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE475E01026",
    "curr_date": "Jun 12, 03:30 PM",
    "curr_time": "08:13 AM",
    "last_traded_at": "Jun 12, 03:30 PM IST",
    "bse_nse_vol": "2.38 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 12, 2026",
    "traded_date_str": "2026 06 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/caplin-point-lab-640544-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Caplin Point Laboratories Ltd to 52-Week High of Rs 2422.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-new-52-week-high-at-rs24224-4049070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_priceRelatedfactors_4049070.png",
        "date": "2026-06-12 11:05:58",
        "description": "With a sustained seven-day rally culminating in a fresh 52-week high of Rs 2422.4 on 12 Jun 2026, Caplin Point Laboratories Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market over the past year."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Caplin Point Laboratories Ltd to 52-Week High of Rs 2405.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-new-52-week-high-at-rs24054-4043853",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_priceRelatedfactors_4043853.png",
        "date": "2026-06-10 10:06:49",
        "description": "With a decisive surge to Rs 2405.4 on 10 Jun 2026, Caplin Point Laboratories Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over the past week."
      },
      {
        "title": "Caplin Point Laboratories Ltd Upgraded to Hold on Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-upgraded-to-hold-on-technical-and-financial-improvements-4043524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_mojoScore_4043524.png",
        "date": "2026-06-10 08:23:22",
        "description": "Caplin Point Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators and sustained financial performance. The upgrade, effective from 09 June 2026, is driven by enhanced technical trends, solid financial results, stable quality metrics, and a valuation that balances growth prospects with market realities."
      },
      {
        "title": "Caplin Point Laboratories Ltd Surges 7.52% to Day's High of Rs 2281 — Outperforms Sector by 6.72 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-intraday-high-with-752-surge-on-9-june-2026-4041358",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_priceRelatedfactors_4041358.png",
        "date": "2026-06-09 15:46:56",
        "description": "The Sensex edged up 0.54% on 09 Jun 2026, but Caplin Point Laboratories Ltd outpaced the broader market with a 7.52% gain, reaching an intraday high of Rs 2281. This 6.72 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Caplin Point Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4040069",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_technicaldot_4040069.png",
        "date": "2026-06-09 08:01:31",
        "description": "Caplin Point Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish trend on weekly charts. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and relative strength against the Sensex suggest a cautiously optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-4036840",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_mojoScore_4036840.png",
        "date": "2026-06-08 10:10:57",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-4037005",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_mojoScore_4037005.png",
        "date": "2026-06-07 10:10:33",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-4037160",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_mojoScore_4037160.png",
        "date": "2026-06-06 10:10:33",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-amid-mixed-signals-4029527",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CaplinPointLabo_technicaldot_4029527.png",
        "date": "2026-06-02 08:05:29",
        "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily moving averages and a 1.66% decline in the latest session, the stock’s weekly and monthly technical indicators present a complex picture that investors should carefully analyse."
      }
    ],
    "total": 624,
    "sid": "640544",
    "stock_news_url": "https://www.marketsmojo.com/news/caplin-point-laboratories-640544"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "29-May-2026",
      "details": "Annual Secretarial Compliance report for the year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "22-May-2026",
      "details": "Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "21-May-2026",
      "details": "Transcript for Earnings call- Q4- FY 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16",
          "dt": "2016-10-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Caplin Point Laboratories Ltd to 52-Week High of Rs 2422.4

2026-06-12 11:05:58

With a sustained seven-day rally culminating in a fresh 52-week high of Rs 2422.4 on 12 Jun 2026, Caplin Point Laboratories Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market over the past year.

Read full news article

Broad-Based Technical Strength Lifts Caplin Point Laboratories Ltd to 52-Week High of Rs 2405.4

2026-06-10 10:06:49

With a decisive surge to Rs 2405.4 on 10 Jun 2026, Caplin Point Laboratories Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over the past week.

Read full news article

Caplin Point Laboratories Ltd Upgraded to Hold on Technical and Financial Improvements

2026-06-10 08:23:22

Caplin Point Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators and sustained financial performance. The upgrade, effective from 09 June 2026, is driven by enhanced technical trends, solid financial results, stable quality metrics, and a valuation that balances growth prospects with market realities.

Read full news article

Caplin Point Laboratories Ltd Surges 7.52% to Day's High of Rs 2281 — Outperforms Sector by 6.72 Percentage Points

2026-06-09 15:46:56

The Sensex edged up 0.54% on 09 Jun 2026, but Caplin Point Laboratories Ltd outpaced the broader market with a 7.52% gain, reaching an intraday high of Rs 2281. This 6.72 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Caplin Point Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-06-09 08:01:31

Caplin Point Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish trend on weekly charts. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and relative strength against the Sensex suggest a cautiously optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Caplin Point Laboratories Ltd is Rated Sell

2026-06-08 10:10:57

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Caplin Point Laboratories Ltd is Rated Sell

2026-06-07 10:10:33

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Caplin Point Laboratories Ltd is Rated Sell

2026-06-06 10:10:33

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Signals

2026-06-02 08:05:29

Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily moving averages and a 1.66% decline in the latest session, the stock’s weekly and monthly technical indicators present a complex picture that investors should carefully analyse.

Read full news article

View All News